SecSonar.com

Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Mirum Pharmaceuticals, Inc. (MIRM) is a Biotechnology company based in US with a market capitalization of $5.1B. Revenue grew 54.7% year-over-year and the company generated $54.9M in free cash flow. This page tracks MIRM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 334 employees · IPO Jul 18, 2019

Valuation

Valuation & price

$102.19 · as of May 17, 2026 · -18.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

16.18

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$126$88.03$50.47Jul 25Dec 25Jul 26Jul 7, 25$50.47Jul 9, 25$53.46Jul 11, 25$52.66Jul 15, 25$51.98Jul 17, 25$52.73Jul 21, 25$51.95Jul 23, 25$53.05Jul 25, 25$51.83Jul 29, 25$51.17Jul 31, 25$51.68Aug 4, 25$52.24Aug 6, 25$53.39Aug 11, 25$65.87Aug 13, 25$65.14Aug 15, 25$67.93Aug 19, 25$65.16Aug 21, 25$69.06Aug 25, 25$71.81Aug 27, 25$74.65Aug 29, 25$73.87Sep 3, 25$74.61Sep 5, 25$76.06Sep 9, 25$77.69Sep 11, 25$75.99Sep 16, 25$73.79Sep 18, 25$75.32Sep 22, 25$73.93Sep 24, 25$74.26Sep 26, 25$72.76Sep 30, 25$73.31Oct 2, 25$71.75Oct 6, 25$72.53Oct 8, 25$72.85Oct 10, 25$72.71Oct 14, 25$73.28Oct 16, 25$74.42Oct 21, 25$68.98Oct 23, 25$69.41Oct 27, 25$71.58Oct 29, 25$70.46Oct 31, 25$72.65Nov 4, 25$70.97Nov 6, 25$67.72Nov 10, 25$69.71Nov 12, 25$70.78Nov 14, 25$71.44Nov 18, 25$72.19Nov 20, 25$69.16Nov 25, 25$71.76Nov 28, 25$73.05Dec 2, 25$69.88Dec 4, 25$71.53Dec 8, 25$67.90Dec 10, 25$64.67Dec 12, 25$65.00Dec 16, 25$67.05Dec 18, 25$70.28Dec 22, 25$81.07Dec 24, 25$80.75Dec 29, 25$80.21Jan 2, 26$78.07Jan 6, 26$76.46Jan 8, 26$81.60Jan 12, 26$89.50Jan 14, 26$90.65Jan 16, 26$91.05Jan 21, 26$93.27Jan 23, 26$94.29Jan 27, 26$99.27Jan 29, 26$102.92Feb 2, 26$103.80Feb 4, 26$103.96Feb 9, 26$100.54Feb 11, 26$99.88Feb 13, 26$103.10Feb 18, 26$105.10Feb 20, 26$105.16Feb 24, 26$107.48Feb 26, 26$92.19Mar 2, 26$90.09Mar 4, 26$93.04Mar 6, 26$86.30Mar 10, 26$90.93Mar 12, 26$89.78Mar 17, 26$96.55Mar 19, 26$90.72Mar 23, 26$89.43Mar 25, 26$90.17Mar 27, 26$88.44Mar 31, 26$92.38Apr 2, 26$94.17Apr 7, 26$95.65Apr 9, 26$98.95Apr 13, 26$96.49Apr 15, 26$96.40Apr 17, 26$97.95Apr 22, 26$94.31Apr 24, 26$91.49Apr 28, 26$94.00Apr 30, 26$97.31May 4, 26$105.79May 6, 26$110.08May 8, 26$107.16May 12, 26$106.88May 14, 26$111.39May 18, 26$95.49May 20, 26$96.95May 22, 26$98.62May 28, 26$99.60Jun 1, 26$96.33Jun 3, 26$91.84Jun 5, 26$93.48Jun 9, 26$95.48Jun 11, 26$99.54Jun 15, 26$101.00Jun 17, 26$102.04Jun 22, 26$107.77Jun 24, 26$114.97Jun 26, 26$123.77Jul 2, 26$125.59
$50.2752-week range$125.59
Loading valuation history…

Fundamentals

Key fundamentals

$5.1B

Market cap

54.7%

Revenue growth (YoY)

80.7%

Gross margin

$54.9M

Free cash flow (USD)

-$63.9M

Net debt

Net cash position

5.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$19.1MFY 2022$77.1MFY 2023$186.4MFY 2024$336.9MFY 2025$521.3M
$0$521.3M

Free cash flow by year

2018 → 2025

FY 2018$-7.9MFY 2019$-39.6MFY 2020$-89.3MFY 2021$-151.8MFY 2022$-120.4MFY 2023$-91.1MFY 2024$9.3MFY 2025$54.9M
-$7.9M$54.9M

Gross margin by year

2021 → 2025

FY 202190.1%FY 202283.9%FY 202374.8%FY 202475.8%FY 202580.7%
90.1%80.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $327K · 10b5-1 PlanHowe Jolanda · SVP, GLOBAL CONTROLLER · $326.5KJul 2, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 18, 2026Filing
  • 8-K eventConvertible Notes IssuedMay 18, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventPhase 2b Study ResultsMay 4, 2026Filing
  • 8-K eventPhase 2b Study ResultsApr 27, 2026Filing
  • 8-K eventFinancial Statements FiledApr 8, 2026Filing

Questions

Frequently asked questions

What is Mirum Pharmaceuticals, Inc.'s market cap?

Mirum Pharmaceuticals, Inc. (MIRM) has a market capitalization of $5.1B.

What is MIRM's P/E ratio?

A meaningful P/E ratio is not available for MIRM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MIRM's price-to-book (P/B) ratio?

MIRM trades at 16.18 times book value per share.

Are insiders buying MIRM stock?

SEC Form 4 filings show no open-market insider buys at Mirum Pharmaceuticals, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

LEGN

Legend Biotech Corporation

$5B

CRSP

CRISPR Therapeutics AG

$5.4B

CGON

CG Oncology, Inc. Common stock

$5.4B

CAI

Caris Life Sciences, Inc.

$4.7B

LQDA

Liquidia Corporation

$5.5B

LGND

Ligand Pharmaceuticals Incorporated

$4.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.